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The COVID-19 pandemic presents new challenges in behavioral healthcare.  Americans may
face anxiety surrounding the virus, economic strain, isolation, and grief, putting them at
increased risk for depression symptoms. This Doctor of Nursing Practice (DNP) quality
improvement project aimed to increase depression screening rates and utilized data from a
Federally Qualified Health Center (FQHC) to identify population groups at higher risk for
depression symptoms during the COVID-19 pandemic. Using the Patient Health Questionnaire
(PHQ) depression screening tool, a statistical analysis determined if being tested for COVID-19
or testing positive for COVID-19 had an impact on depression symptoms. Additionally, this
project identified if there was a change in behavioral health utilization at the FQHC. The results
of this project found that depression symptoms did not increase during the COVID-19 pandemic
in patients at the FQHC. The FQHC is successful in meeting their depression screening goal but
positive depression screening was missed in visit documentation about 10% of the time.
Behavioral health utilization was difficult to estimate due to a loss of providers at the FQHC.
Overall, this project provided insight into the effect the COVID-19 pandemic had on depression
symptoms and the impact on behavioral healthcare at the FQHC.
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Depression Screening and COVID-19
The purpose of this paper is to detail a Doctor of Nursing Practice (DNP) quality
improvement project designed to examine data regarding depression symptoms and COVID-19
at a Federally Qualified Health Center (FQHC) in Northwest Arkansas.  This paper will discuss
the behavioral health needs that surround the COVID-19 pandemic and the strategies to identify
patients who could benefit from behavioral health services.  Data was collected from the
electronic medical record.
Background and Significance
COVID-19 is a novel coronavirus that was first identified in December 2019 in Wuhan,
China (Centers for Disease Control and Prevention [CDC], 2020).  As of March 2021, according
to the World Health Organization (WHO), there have been over 117 million confirmed cases in
the world.  COVID-19 is primarily passed through person-to-person transmission via respiratory
droplets and has been spreading rapidly across communities since first identified.  Due to its
method of transmission, social distancing measures are vital in mitigating viral spread.  Public
health measures have included school and non-essential business closures, bans on public
gatherings, travel restrictions, contact tracing, and isolation/quarantine measures (CDC, 2020).
People with COVID-19 may experience a wide range of symptoms from mild to severe.  The
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most common symptoms are fever, cough, and fatigue, and the most common complication is
pneumonia.
The first case of local transmission of COVID-19 in the United States (US) occurred in
January (CDC, 2020).  A public health emergency was declared on January 31st, but the US
lagged in creating and dispersing functional COVID-19 test kits.  A national emergency was
declared on March 13th and the US Food and Drug Administration (FDA) began allowing
private companies to develop tests (FDA, 2020).  By the end of March, there were confirmed
cases in all 50 states and nationwide shortages of personal protective equipment (CDC, 2020).
As of March 2021, the United States has more active cases of COVID-19 than any country in the
world (WHO, 2020).  The death count in the US surpassed 550,000 as of March 2021 (CDC,
2021).
The FDA declared an emergency use authorization for the first vaccine for the prevention
of COVID-19 on December 11, 2020 (FDA, 2021). As of March 2021, there are three vaccines
authorized for the prevention of COVID-19: Pfizer-BioNtech, Moderna, and Johnson & Johnson
/Janssen (CDC, 2021).  There are two additional vaccines in large-scale (phase 3) clinical trials.
The COVID-19 pandemic has resulted in changes in the daily life of many Americans,
such as changes in employment (e.g., remote access, furlough, and unemployment),
home-schooling children, and isolation from family and friends (CDC, 2020).  Nearly one in four
Americans filed for unemployment by the end of March 2020 (U.S.  Bureau of Labor Statistics,
2020).  Historically, morbidity and mortality related to mental health have spiked during times of
economic recession (Frasquilho, et al., 2016).  Data from a previous outbreak of infectious
disease indicates that the number of people whose mental health was affected was greater than
the number of people who were physically affected by the infection (Reardon, 2015).  The
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recommended social distancing measures may also contribute to poor mental health outcomes.
A rapid review found that quarantine measures are associated with negative psychosocial effects
including depression symptoms (Rohr et al., 2020).
Prior to COVID-19, the United States healthcare system was unable to meet the mental
healthcare needs of Americans.  The prevalence of depression in adults over the age of 20 is
8.1% (Brody et al., 2018).  Despite this, only 6% of adults in the US reported receiving
outpatient mental health treatment in the past 12 months (Han, et al., 2016).  Of those diagnosed
with a mental health condition, 33% reported having received mental health services in the past
year (Walker et al., 2015).  The demand for behavioral health services exceeds the availability of
providers; approximately 80% of all US counties are designated as mental health professional
shortage areas (HRSA, 2020).  In Arkansas, a mental health professional shortage area
(MHPSA), there are 13 psychiatric workers per 100,000 residents (Beck, et al., 2018).
Furthermore, those that received regular mental health care prior to the COVID-19 outbreak may
find their behavioral health care providers inaccessible. In China, 17.2% of patients reported
they stopped taking their psychiatric medications because they could not gain access to
prescriptions from physicians during the outbreak (Zhou et al., 2020).
After the COVID-19 outbreak in China, there was a 74% drop in the reported emotional
wellbeing of the Chinese population (Yang & Ma, 2020). In a survey of American adults, fear of
COVID-19 was positively correlated with depression and anxiety symptoms (Fitzpatrick et al.,
2020).  Another survey identified Americans were three times more likely to have depression
symptoms during the COVID-19 pandemic as compared to before (Ettman, et al., 2020). The
attributes: lower income, increased stressors, and less money in savings were associated with
greater depression symptoms. Following the immediate effects on morbidity and mortality,
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disasters have lasting impacts on the mental well-being of survivors.  An analysis of data from
Hurricane Katrina uncovered the stressors: loss of a loved one, fear for one’s safety, and
uncertain access to medical care had significant negative effects on mental health for 12 years
following the disaster (Raker et al., 2020).
Some protective variables may reduce the mental health risks that follow trauma. For
example, higher levels of perceived social support two months after exposure to a traumatic
event can reduce the development of depression symptoms (McGuire et al., 2018).  In January
2020, the National Health Commission of China integrated mental health crisis interventions into
their general COVID-19 disease prevention (Li et al., 2020).  The Anxiety and Depression
Association of America is calling for a proactive mental health response amid the COVID-19
pandemic (Marques et al., 2020).  These strategies include an early identification of mental
health symptoms through valid screening tools and a timely referral to appropriate behavioral
health services.
Problem Statement
The problem statement for this DNP quality improvement project is that the behavioral
health services at the clinic may not have met the increased demand as a result of the
COVID-19 pandemic. Data regarding COVID-19, depression screening rate, depression
symptoms, and behavioral health utilization would provide useful insight into the clinic’s
ability to meet the need for behavioral health services for patients during this tumultuous time.
Individuals experiencing stress related to the COVID-19 pandemic may be at greater risk for
experiencing depression symptoms (Ettman, et al., 2020).  Due to this being an emerging
problem, the clinic will benefit from information that identifies populations that are at risk and
evaluates the availability of behavioral health services.
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Purpose Statement
The purpose of this DNP quality improvement project is to ensure the clinic is reaching
its goal for depression screening rate and analyze data on depression symptoms and behavioral
health services at the clinic before and during the COVID-19 pandemic.  Identifying the
mental health risks associated with COVID-19 can allow for a targeted response from
healthcare providers and connect patients in need with treatment options.  Analyzing this data
will inform the clinic which populations may be at greater risk for depression symptoms
during this unprecedented time and allow for a proactive response. This information will also




The objective of this needs assessment is to identify the gaps in the mental healthcare of
patients affected by COVID-19 at an FQHC in Northwest Arkansas.  The outbreak of COVID-19
has caused an increase in stress in many populations due to fear of illness, financial stress, and
social isolation (Mazza et al., 2020).  These stressors may be especially pronounced in those of
low socioeconomic status (Raker et al., 2020).  Stressful life events have been linked to changes
in the brain that make someone more likely to develop depression symptoms (Yang et al., 2015).
Participants
The participants of this needs assessment were chosen as key stakeholders involved in
mental healthcare services at the clinic.  The Quality Manager, Behavioral Health Director,
Director of Nursing, Outreach Coordinator, Office Manager, and Clinical Manager provided
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insights regarding the effect of COVID-19 on mental health.  Collectively, the diverse role of
participants offered key insights into the gaps in care for this group.
Rationale
Mental health services are most efficient when integrated with primary healthcare
services (Balasubramanian et al., 2017).  Patients who have been tested for COVID-19 may
experience anxiety about their health and the health of their household members, as well as
reduced or lack of income, food insecurity, and disruption of normal social activities.  The clinic
typically administers the Patient Health Questionnaire (PHQ) depression screening tool to all
patients over the age of 12 at every visit.  This practice is well established at the clinics, and staff
is familiar with the screening tool and procedure. Patients are often offered behavioral health
services the same day that they screen positive for depression symptoms.
Data Collection
The needs assessment utilized key informants to collect information regarding the gaps in
mental healthcare of patients who are tested for COVID-19. The questions were broad in order
to generate observations and ideas from staff about unmet needs and possible strategies to
address these described needs.  Staff members were asked to identify the gaps in care as well as
why these gaps exist, negative outcomes that may result from these gaps, previous strategies that
were used in an attempt to close these gaps, and suggestions on possible solutions.  One final
question assessed the workplace culture and readiness to participate in the project.  A total of six
open-ended questions were presented to the staff members.
Interviews
A total of six staff members were interviewed.  A convenience sample of participants was
selected for the interviews based on experience and expertise related to the project problem.
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Interviews were conducted over the last week of May 2020 and each took approximately 10-15
minutes to complete.  Please see Appendix G for the needs assessment questionnaire.
Implementation and Analysis
The interviews were completed in person, over the phone, and via email communication.
Clarification was provided when requested and staff were encouraged to provide any additional
information they felt was relevant.
One of the key findings included a common consensus that adaptations are needed in
current practices in order to meet the emerging mental healthcare needs associated with the
COVID-19 pandemic.  Multiple staff members identified that many patients who come for
testing are not established patients.  It was suggested that screening patients for depression who
are also tested for COVID-19 would identify at-risk patients and connect them with services that
previously may have been financially inaccessible to them, given that FQHCs provide services to
all people regardless of their ability to pay.
Multiple staff members reported that patients expressed stress related to financial strain
and fear surrounding the virus.  A patient outreach team member identified that the number of
patients in need of food was at an all-time high since the start of this team member’s
employment.  A staff member reported that behavioral health counselors conducted some
telemedicine visits via webcam but many via telephone due to patients’ technological access.
One staff member reported that the feasibility of the intervention would be a significant concern
as the clinic is already overwhelmed with the current patient volume related to COVID-19.  In
addition, all staff interviewed felt that the staff would support initiatives to improve gaps in care.
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This data is useful for identifying gaps to focus on developing strategies to improve
resulting patient outcomes.  The data also demonstrates a workplace culture that is open to
changes and supportive of evidence-based practice.
Aim and Objectives
Aim
The aim of this project was to identify if there was a change in depression symptoms or
behavioral health utilization during the COVID-19 pandemic.  It is important to work on this
now because a culmination of variables associated with COVID-19 contribute to the
development of depression symptoms and the accessibility of behavioral health treatment.
Objectives
● Ensure 80% of adult patients are screened with the PHQ
● Ensure positive PHQ screening is addressed during the appointment based on
documentation
● Determine if there is an increase in PHQ score in adult patients during the three-month
implementation period compared to the same three months in the previous year
● Identify if there is a specific demographic group that had greater change in mean PHQ
score from the three-month implementation period compared to the same three months
in the previous year
● Identify if there was a change in behavioral health utilization from the three-month
implementation period compared to the same three months the previous year
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Review of Literature
A literature review was conducted using MEDLINE Complete (EBSCO) with the key
words COVID-19, coronavirus, mental health, mental illness, mental disorder, psychiatric
illness, depression screening tool, integrated behavioral health, and telemedicine.  Articles were
limited to publication dates 2015-2020.  The search was assisted by a research librarian and
initially yielded 526 articles.  Exclusion criteria included editorials and articles that were not
relevant to the project topic. The search uncovered grey literature from the Centers for Disease
Control and Prevention (CDC), World Health Organization (WHO), and data from Health
Resources and Services Administration (HRSA).  Twenty-four articles were included in this
literature review.
The COVID-19 pandemic is an unprecedented public health crisis.  Many are impacted
directly through exposure, infection, hospitalization or death and indirectly through financial
stress and job loss.  In an online survey conducted before and during the COVID-19 pandemic,
participants scored significantly worse in depression, anxiety, wellbeing, and resilience measures
during the outbreak (van Agteren et al., 2020).  The Principles of Mental Healthcare during the
COVID-19 Pandemic (2020) established by the European Psychiatric Association recommends
that health policy developers consider the consequences of the restrictive social distancing
measures.  Previously unaffected populations may experience mental disruptions and disorders
as a result of isolation, monitoring, and quarantining (Rohr et al., 2020).
Special Populations
Female Gender/Pregnancy
Prior to the COVID-19 pandemic, data demonstrated a higher prevalence of depression in
women than men in the United States (National Institute of Mental Health, 2017).  During the
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COVID-19 outbreak in Spain, female gender was a predictor of post-traumatic stress symptoms
and anxiety in a large-scale survey (González-Sanguion et al., 2020).  Additionally, female
healthcare workers were more likely than their male counterparts to suffer anxiety and
depression symptoms during the COVID-19 outbreak. In China, pregnant women assessed for
depression had significantly higher rates than those assessed prior to the outbreak (Wu, et al.,
2020).  Pregnant women in Canada have reported higher levels of depression, anxiety, and
symptoms of PTSD since the declaration of the COVID-19 pandemic (Berthelot et al., 2020).
Older Adults
Age was positively correlated with a reduction in emotional wellbeing during the
pandemic in China (Yang & Ma, 2020).  Risk for severe illness from COVID-19 increases with
age (CDC, 2020). People over age 55 have more severe psychological symptoms during the
pandemic possibly due to anxiety and fear associated with their higher likelihood of death if
infected with COVID-19 (Tian et al., 2020).
COVID-19 Positive Patients
There is a strong association between the severity of physical symptoms of COVID-19
and the depth of psychological impact (Wang et al., 2020).  A large-scale survey in Spain
revealed that current or previous symptoms of COVID-19 were positively correlated with
depression, anxiety, and PTSD symptomology (González-Sanguino et al., 2020).  Additionally,
respiratory symptoms caused by COVID-19 have been linked to the release of pro-inflammatory




The US Preventative Task Force (2016) recommends routine screening for all adults,
regardless of risk factors for depression.  The Patient Health Questionnaire-2 (PHQ-2) and
Patient Health Questionnaire depression module (PHQ-9) are the most widely used depression
screening tools (Maurer et al., 2018).  The PHQ-9 is a nine-item screening instrument used for
detecting depression and classifying the severity (Levis et al., 2020).  Additionally, the PHQ-2
makes up the first two items of the PHQ-9 and can be used to identify patients for further
evaluation with the complete PHQ-9.  In a systematic review and meta-analysis, it was identified
that using this combination of the PHQ-2 and PHQ-9 did not result in a statistically significant
difference in screening outcomes than the PHQ-9 alone (Levis et al., 2020).  Additionally, this
strategy reduced the number of participants who need to complete the full PHQ-9 by 57%.
Furthermore, the PHQ-2 has optimal sensitivity and specificity in the identification of depression
symptoms (Staples et al., 2019).  It is also brief enough to be administered during short
interactions or consultations.  The PHQ-2 has demonstrated its validity with diverse population
groups (Gelaye et al., 2016; Rancans et al., 2018).
Telemedicine
After gaining experience during the peak of the outbreak in Italy, the Department of
Mental Health and Addiction in Lombardy recommended turning to appropriate e-technologies
and procedures and developing interventions to mitigate the harmful effects of quarantine (de
Girolamo et al., 2020).  In addition, the Italian Society of Epidemiological Psychiatry (2020)
recommended outpatient visits be replaced with phone and video calls when possible.
Psychological assessment and treatment via telemedicine for depression is found to be clinically
effective and comparable to therapy delivered in-person (Palylyk-Colwell & Argáez, 2018).  In
the United States, prior to the COVID-19 pandemic, restrictions on Medicare and other private
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payers’ reimbursement limited the accessibility of telemedicine behavioral health services (Lau
et al., 2020).  Yet, following the expansion of telemedicine by CMS with the 1135 waiver,
healthcare organizations were financially able to increase their virtual behavioral health services.
Telemedicine services allow the behavioral health providers to continue to meet with patients for
counseling sessions and appointments for medication management while also keeping the patient
safe in their home and avoiding opportunities to spread COVID-19.
Integrated Behavioral Health
Integrated behavioral health is a care model that involves coordinating behavioral health
with primary care in order to improve patient outcomes. Integrating behavioral health care into
primary care results in improved mental and physical health outcomes as well as enhanced
quality of life (Flynn et al., 2020).  This care integration promotes collaboration among providers
and gives nonmedical providers a role in augmenting primary care.  Patient participation in
integrated behavioral health can result in the improved management of chronic illnesses and
increased access to behavioral health services (HRSA, 2020).  The United Kingdom National
Health Service (NHS) described many benefits from its integrated behavioral health model
during the COVID-19 pandemic (Tracy et al., 2020). The NHS formed mental health and
physical health crisis response teams that focused on mitigating both the physical and emotional
risks of COVID-19.  Together the crisis teams were able to respond efficiently to patients’
emerging health needs.
Conclusion
Evidence indicates support for integration of mental health services into the care of
patients that are tested for COVID-19, as well as special considerations made to ensure at-risk
populations are screened and treated for depression. Populations including female gender,
16
pregnancy, older adults, and patients that have tested positive for COVID-19 or have symptoms.
The PHQ can be quickly incorporated into primary care practice so that patients can be screened
for depression symptoms.  Appropriate follow-up visits with the patients who screen positive are
recommended.  Telemedicine services will allow patients increased access to behavioral
healthcare while decreasing opportunities for viral spread.
Theoretical Framework
The conceptual framework that guided this DNP project is the Johns Hopkins Nursing
Evidence-Based Practice Model and Process (Dang & Dearholt, 2018).  This model provided
guidance for the development of the practice question, gathering of evidence, translation, as well
as outcome analysis.  The Johns Hopkins Nursing Evidence-Based Practice Model and Process
(JHNEBP) outlines the steps for the project as well as the practice environment necessary for
implementation of evidence-based practice changes. The model is designed to prompt continued
learning at all steps of the process.  The identification of the problem and development of the
practice question is detailed through the Practice, Evaluation, and Translation (PET) process.  It
presents guidelines for identifying and synthesizing quality evidence that supports the change.
The recommendations for translation are practical and detailed.  This DNP project utilized this
framework in order to keep ideas and evidence organized and ensure successful translation.
Theory
Inquiry
According to the JHNEBP, before the initiation of the process it is vital to cultivate a
culture of inquiry within the healthcare organization. The inquiry process involves approaching
one’s practice with ongoing curiosity regarding the best evidence for clinical practice.  The
JHNEBP model proposes questions that should drive the nurse’s practice including whether the
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best evidence is being used and whether the care provided is optimal.  The culture of inquiry
outlined in the JHNEBP is demonstrated at the clinic through its staff’s willingness to adapt to
emerging recommendations in behavioral healthcare practice.
Practice
Following inquiry in the JHNEBP is the Practice phase. When developing an answerable
practice question, it is necessary to use an interdisciplinary team and to clearly define the
problem.  In this case, the interdisciplinary team consisted of administrators, health care
providers, nurses, medical assistants, and the behavioral health team.  Through the Needs
Assessment, the problem was identified as a lack of mental health focus related to the COVID-19
pandemic, a practice that has been proven to be evidence-based as the integration of behavioral
health and primary care enhances the patient’s experience of care (Balasubramanian et al., 2017).
As this has been a long-term policy at this FQHC, many staff members have observed the
effectiveness and efficiency of the integrated behavioral health model.
The next step in the Practice phase of the JHNEBP is the formulation of a narrowly
focused question that uses the PICOT mnemonic.  The developed practice question which
follows the PICOT mnemonic is: In patients at an FQHC, how does the COVID-19 pandemic,
compared to prior to the COVID-19 pandemic, affect the demand for and availability of
behavioral health services?
Evidence
The second phase of the JHNEBP model PET process is the evidence phase which
includes searching, appraising, summarizing, and synthesizing the evidence.  The developed
recommendations for change should be based upon the synthesis of quality evidence.  The
evidence was synthesized in the review of literature which demonstrated the need for behavioral
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health interventions to be integrated into the management of COVID-19.  Once sufficient
evidence has been analyzed and determined to be both compelling and consistent, the practice
change can begin the translation process.
Translation
Translation is the third phase of the PET process. In this phase it is necessary to consider
the feasibility and appropriateness of the practice change and then develop an action plan.  Major
barriers considered during development of the action plan include time and data management.  It
will be important to stay organized when managing large volumes of data and also conducting
multiple statistical analyses.
Best Practices
Best Practices is the next phase in the JHNEBP model. This phase evaluates the
outcomes of the practice change.  The mean PHQ of adult patients during the three month period
of 2019 was compared to the mean PHQ of adult patients during the same three months of 2020.
Demographic data was collected in order to compare the demographics of the 2019 and 2020
patients to ensure the population samples were comparable and validate findings.
Practice Improvements
Practice Improvements is the final phase of the JHNEBP. This included reporting
outcomes to stakeholders, identifying the next steps in continued practice change, and
disseminating findings.  Findings were disseminated and utilized to develop a proactive
behavioral health response at the clinic.
Implications for Practice
The JHNEBP model allows for the assurance of sustainability in practice through the
considerations of fit, feasibility, and appropriateness. In order to ensure successful action
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planning, one must consider internal and external factors.  The JHNEBP model is an open
system and is continually influenced by internal and external factors.  External factors include
accreditation bodies, legislation, quality measures, and standards.  External factors influencing
this project include payers’ modification of reimbursement for telemedicine services due to
COVID-19.  Additionally, recommendations from the Centers for Disease Control and
Prevention regarding the continuation of in-person vs. telemedicine visits influenced the project.
Internal factors include organizational culture, leadership, practice environment, technological
access, and time.  An internal factor that influenced the project is staff shortages due to employee
exposure to COVID-19.  Another internal factor is the availability of behavioral health
translators for patients that are non-English speaking. Translators for behavioral health need
special training in order to provide culturally competent care (Benuto & O’Donohue, 2016).
According to the JHNEBP model, these factors can then be classified as barriers or facilitators to
the success of the practice change.
Summary
The JHNEBP model was used to develop the practice question, collect and analyze
evidence, translate the evidence into practice, and evaluate the outcomes of this DNP project




The project design was quality improvement.  The desired outcome was the
determination of the impact of COVID-19 on demand and availability of behavioral health
services of patients with depression symptoms at the FQHC.  The hypothesis was that adult
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patients in December 2020-February 2021 would have an elevated mean PHQ score than adult
patients in December 2019- February 2020.  Other variables that were analyzed include PHQ
scores of demographic groups, patients tested for COVID-19, and the COVID-19 test results.
Additional outcomes included that the FQHC would reach its goal of screening 80% of all adults
with the PHQ-2 and would address all positive screenings in visit documentation. The data
collection phase occurred over a three-month time period.
The FQHC aims to screen all adults for depression, identify behavioral health needs, and
connect patients with behavioral health services. Analyzing this data aligns with the
organization’s goals.  Due to being an FQHC, the clinics have quality measures related to
depression screening.  They have two yearly objectives applicable to behavioral health:
increasing the behavioral health consultant’s visits compared to the previous year and increasing
the total behavioral health telemedicine visit rate.
Project Design
A weekly report was generated during the implementation period that identified the
percent of adult patients that are screened with the PHQ-2.  Additionally, chart reviews were
utilized to identify instances in which patients had a positive PHQ-2 screening that was not
addressed in the visit documentation.  These charts were categorized according to visit reason in
order to identify any potential patterns.
The data that was collected through a report generated from the EMR included the
patient’s medical record number, age, gender, race, ethnicity, PHQ results, COVID-19 test
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results, and referral to behavioral health. The data was organized in Excel and analyzed using
SAS and SPSS.
Setting
The clinic is an FQHC in Northwest Arkansas and includes four primary care sites in
Fayetteville, Springdale, Rogers, and Siloam Springs. There are also seven school-based health
centers throughout Northwest Arkansas.  As of March 10, 2021, there are 368 active cases of
COVID-19 in Benton County and 296 active cases in Washington County (Arkansas Department
of Health [ADH], 2021).  As of March 2021, 16.12% of the population aged 16 and up in
Arkansas, have been vaccinated with at least one dose of the COVID-19 vaccine, while 9.1% of
this population group has been fully vaccinated.
Study Population
The study used convenience sampling.  All adult patients that presented to the clinic
during the implementation period and underwent the PHQ screening tool were included in the
results.
FQHCs traditionally serve patients of low socioeconomic status.  The clinic has primarily
Hispanic and Marshallese patients who have been disproportionately affected by COVID-19 in
the Northwest Arkansas area (ADH, 2020).  Marshallese make up 1.5%-3% of the population in




Data from adult patients that presented to the clinic during the three month
implementation period of December 2020-February 2021 was utilized for the study. Data
collected from adult patients that presented during the same three months of the previous year
was also utilized.
Consent Procedures
A waiver of consent was pursued per the University's Institutional Review Board
recommendation.  This project was a retrospective data analysis and aimed to optimize current
clinic depression screening practices but did not change the standard of care provided to patients.
Study Measures
Conceptual Definitions. The independent variable of this study is whether the patient
presented for a visit in December 2019-February 2020 or December 2020-February 2021.  Other
independent variables include race, gender, age, whether the patient was tested for COVID-19,
and their COVID-19 test results. The dependent variables include the patient's results on the
PHQ-2 screening tool, depression screening rate, and addressing the PHQ-2 in the assessment or
plan.
The level of depression can be defined conceptually as mild, moderate, or severe.
Another conceptual definition would be for COVID-19 positivity which is identified with
detected RNA of SARS-CoV-2 on a nasal-pharyngeal swab.
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Operational Definitions. An operational definition of depression is the numerical score
on the PHQ-2 ranging from 0-6.  The operational definition for COVID-19 positivity is that the
sample surpassed the detection limit of SARS-CoV-2 RNA.
Outcome Measures. The patients’ COVID-19 test results, PHQ-2 screening results,
information on referral to behavioral health services, and demographic information were
obtained from eClinicalWorks.
Process Measures. The percentage of patients that were screened with the PHQ-2 was
assessed throughout the implementation period.  It was evaluated weekly through chart reviews
that positive PHQ-2 screenings were addressed in visit documentation.
Balancing Measures. Information was gathered on the visits coded per provider per day
for the LCSWs in order to estimate behavioral health utilization and appointment availability.
Benefits and Risks
There are minimal risks associated with a depression screening tool.  The subjects could
have loss of confidentiality of data collected.  There is a risk that some patients had a positive
PHQ-2 screening but were not offered appropriate treatment.
Subject Costs and Compensation
There will be no cost or compensation for the participants.
Project Timeline
The actual timeline varied somewhat from the expected timeline. The first needs
assessment was conducted at the clinical site in February and March 2020 and was rendered
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irrelevant following the beginning of the COVID-19 pandemic and rise of cases locally in May
2020. A second needs assessment was conducted in May and June 2020 which resulted in a
delayed timeline. Overall, this shortened the amount of time available for dissemination. Please
see Gantt Chart in Appendix E for timeline.
Resources Needed and Economic Considerations




Weekly data reports were generated through the clinic’s EMR. Data was sorted in
Microsoft Excel and organized into tables. When the clinic fell below their goal depression
screening rate in week 3 of implementation, an analysis was conducted to determine the care
teams with the lowest screening rates. These care teams were reached out to via email and a
discussion was generated regarding barriers to screening patients with the PHQ-2.  Chart reviews
were conducted of charts in which the patient scored 3 or greater on the PHQ-2 screening tool. If
there was a safety concern related to the lack of documentation, then the provider was notified.
The table below displays the evolution of this project over time.
Table 1
Time Frame Proposed Intervention Evolution Over Time
January-March 2020 Conducted initial needs COVID-19 pandemic
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assessment and began
proposal related to increasing
colon cancer screenings
emerged and initially, doctors
weren’t doing colonoscopies
March 2020-May 2020 Recognized that a topic
related to COVID-19 would
need to be selected in order to
proceed with project
It was difficult to
communicate with
stakeholders at clinic due to
them being inundated with
COVID-19
May 2020-July 2020 Started summer clinical and





screening in COVID-19 result
phone call
August 2020 Returned to clinic for fall





was irrelevant as patients
were being screened for
depression in the clinic and
drive through visits had ended
September 2020-November
2020
Modified proposal with the
goal of increasing depression
screening rates
Planned to include data
analysis and identify






clinic is generally reaching
their goal for depression
screening without
intervention





During the pre-implementation phase, the data report requests were completed with the
IT department. The data-report variables were finalized prior to implementation. Approval from
the University’s Institutional Review Board (IRB) was obtained on November 19, 2020, and
implementation began on December 1, 2020.
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Implementation Phase
Evolution of Need. Initially, this project intended to implement the use of a telephone
depression screening tool for patients that were being tested for COVID-19 via drive-thru style.
Following the unpredictability of an emerging public health crisis, the project adapted with the
site as patients were brought inside for clinic visits and COVID-19 testing in September of 2020.
The needs assessment was conducted in the summer of 2020 and identified a need for
increased depression screening at the clinic. However, as clinic procedures transformed from
summer to fall, the clinic’s depression screening rate improved significantly, reaching the clinic
goal of 80%. It was found during implementation that the need for the intervention decreased as
the clinic met their screening rate goal eleven out of the twelve weeks of the implementation
period.
School-Based Clinic Sites. It was recognized in the first few weeks that school-based clinic care
teams had significantly lower depression screening rates than the traditional larger clinic care
teams. The providers at the school-based clinics were contacted and asked to comment on this
phenomenon. The school-based clinics are not staffed with a nurse; they each include an
Advanced Practice Registered Nurse (APRN), Medical Assistant (MA), and a front office staff
member. Due to this, the APRN will have both ‘nurse-only’ visit types and traditional provider
visits. It is not in the clinic’s current protocol to include depression screening in ‘nurse-only’ visit
types. Examples of this visit type include vaccination administration, COVID-19 testing only, or
blood pressure check. Including these visits for the school-based care teams lowered their
calculated depression screening rate. This was discussed with the clinic’s Quality Manager as a
potential area for improvement.
27
This area for improvement was further demonstrated in week four of implementation,
when one school-based provider improved their depression screening rate by 32% in one week
compared to the previous. After reviewing the provider’s schedule and documentation, it was
noted that the provider had a substitute MA from a larger clinic site. This observation gave
notion to the idea that there were some missed opportunities for depression screening at the
school-based sites, the lower screening rate may have more to do with training and routine than
lack of opportunity for screening.
Post- Implementation Phase
Following the implementation phase, data evaluation began. The data was compiled into
an excel spreadsheet and SAS and SPSS were utilized to perform the data analysis.
The results were disseminated at the clinical site with a PowerPoint presentation during
the monthly Quality Team Meeting. The results were disseminated at the DNP intensive in April
2021.
Evaluation of Results
Data Maintenance and Security
Data was collected using the clinic's electronic medical records (EMR) system,
eClinicalWorks (eCW).  The eCW system was used to retrieve information regarding the PHQ
results, COVID-19 testing, behavioral health visits, and demographic data.  No patient
identification information was extracted from the EMR and clinic account number were used to
identify individuals.  Data was compiled on a codebook Excel sheet on the investigator’s
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password protected private computer.  The data was not available to any other accessors without
the investigator’s knowledge and permission.
Data Analysis
Data analysis was completed using a combination of SAS and SPSS with the assistance
of an SMSS tutor. A simple percentage calculation using Excel was used to determine the PHQ-2
screening rate. An independent t-test and dependent t-test were utilized to test the hypothesis that
patients at the FQHC had a higher mean PHQ-2 score during the pandemic. A one-way ANOVA
was used to analyze the PHQ-2 score during both time frames of different demographic groups.
An alpha level of 0.05 was used for all statistical tests. Effect size was calculated using Cohen
d’s for the t-test and for the ANOVA (Cohen, 1973, 1988). Calculating effect size is𝜼2
appropriate for this data as the large sample size can make a very small difference in means
significant. Effect size measures the relationship strength between the independent and
dependent variable.
Behavioral health utilization was estimated using visits coded per provider per day and
referral count to behavioral health from family practice providers. The percent of behavioral
health visits that were conducted via telemedicine was calculated for each month in 2020. Chart
reviews were also conducted for all patients that had a PHQ-2 score of greater than 3 throughout
the implementation period in order to identify instances in which a positive PHQ-2 screening
was not addressed in visit documentation.
Outcome Measures
The independent t-test had a sample size of 4,792 in the earlier time frame and 4,019 in
the later time frame. The mean PHQ-2 score in the earlier time frame was 0.47 (SD=1.28) while
the mean in the later time frame was 0.28 (SD=0.99). This decrease in PHQ-2 score was
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significant. Although, the effect size was very small. Assumption of equal variance is not met,
t-value for unequal variance is reported t(8753.5)=7.67,p<0.0001, d= 0.16.
The sample size of the dependent t-test was 1,720. The mean PHQ score in the first time
frame was 0.35 (SD=1.1) and the mean in the later time frame was 0.19 (SD=0.81). This was
also found to be a significant decrease with a very small effect size. Assumption of equal
variance is not met t-value for unequal variance is reported t(1719)=5.99,p<0.0001, d= 0.14.
A one-way ANOVA was used to determine if there was a difference in changes of PHQ-2
score related to gender. Females were found to have a mean PHQ-2 score of 0.52 (n=3,039,
SD=1.35) in the earlier time frame and a mean of 0.32 (n=2,494, SD=1.06) in the second time
frame. Males had a score of 0.37 (n=1,760, SD=1.13) and 0.22 (n=1,526, SD=0.87) respectively.
There was a significant difference in PHQ-2 scores of females and males, F(1, 8807)= 23.86,
p<0.001, =0.0027. There was not a significant difference found in the change in PHQ-2 scoreη
2
𝑝
related to gender, F(1,8807)=0.80, p=0.37, =0.0001.η
2
𝑝
A one-way ANOVA test was also used to analyze the PHQ-2 scores with respect to race
and ethnicity. The clinic includes seven categories for race and two categories for ethnicity. The
results of the one-way ANOVA are displayed in the table below. There was not a significant
difference found in PHQ-2 scores over the two time frames with respect to race, F(1, 8807)= 0.70,
p<0.65, =0.0005. However, there was a significant difference found in the PHQ-2 scores in theη
2
𝑝
time frames according to ethnicity, although the effect size was very small, F(1,8807)=4.50,
p=0.011, =0.0010. ‘Unreported’ ethnicity had a greater decrease in PHQ-2 score from the firstη
2
𝑝
time frame to the second compared to the other ethnicity groups.
Table 2
PHQ-2 Score and Race
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41 33 1.276 0.667 2.308 1.555




69 70 0.794 0.500 1.748 1.494
Multiple
Races








1341 1093 0.348 0.194 1.074 0.780
White 3111 2546 0.512 0.318 1.335 1.054
Table 3
PHQ-2 Score and Ethnicity


















326 264 0.696 0.289 1.641 0.955
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No correlation was found between the average PHQ-2 score and the patient’s age in
either time frames, r(4017)=-0.08608, p<0.0001, =0.007.𝑓 2
The sample only includes patients that completed a PHQ-2 during the time frames
December 2019-February 2020 and/or December 2020-February 2021. Of this sample, the mean
PHQ-2 score of patients that were ever tested for COVID-19 at the clinic (M=0.19, n=762, SD=
0.82) was compared to the mean PHQ-2 score of patients that were never tested for COVID-19
at the clinic (M=0.26, n=4,977, SD=0.96). This decrease in PHQ-2 score in patients that were




The mean PHQ-2 score of patients that tested positive for COVID-19 (M=0.12, n=291,
SD=0.62)  was compared to the mean score of patients that did not test positive (M=0.26,
n=5,448, SD=0.95). Patients that had not tested positive for COVID-19 at the clinic had a higher




The PHQ-2 screening rate was calculated in two separate ways. The first way aligns with
the clinic’s quality metric and includes any patients that were screened with the PHQ-2 at any
time in the 12 months prior to their service date with the time frame December 2020-February
2021. The clinic was found to meet or exceed their goal of an 80% screening rate 11 of the 12




The PHQ-2 screening rate was also calculated with regards to each visit without consideration of
previous screening. This rate was calculated for each month of the year 2020. This is displayed
in the line graph below.
Graph 2
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Chart reviews were conducted of all patients that had a score of 3 or greater on their
PHQ-2 during December 2020-February 2021 to identify if the positive screening was addressed
in visit documentation. There were a total of 269 positive PHQ-2 screenings throughout the
implementation period and 27 of those were not addressed in the visit documentation.
Approximately 10% of positive PHQ-2 screens were not addressed in visit documentation.
The instances of positive screenings that were not addressed in visit documentation were
categorized according to chief complaint in order to identify any patterns of visit reason in which
a PHQ-2 is less likely to be addressed in visit documentation. The most common visit type in






Behavioral health utilization was estimated using the average visits coded as provider
per day worked by the Licensed Clinical Social Workers (LCSW). The average visits per day in
December 2019-February 2020 was 6.14 as compared to the average visits in the second time
frame, 8.40. This increase in utilization could also be attributed to the clinic losing several
LCSWs. The clinic employed seven LCSWs in December 2019 and was down to three in
January of 2021. Additionally, the referrals from family practice providers to behavioral health
were counted in each time frame. There were 122 referrals to behavioral health from December
2019-February 2020 but only 38 from December 2020-February 2021. This decrease could also
be explained by the fewer LCSWs available during the second time frame.
Below is a graph demonstrating the percent of behavioral health visits with an LCSW
that were completed via telemedicine for each month in 2020. Prior to the COVID-19
pandemic, none of the behavioral health visits were done via telemedicine but this increased





The data analysis demonstrated that the PHQ-2 screening rate was lower in the summer
during the time the needs assessment was conducted. This screening rate improved when the
FQHC returned to traditional clinic visits in the fall. The FQHC missed about 10% of positive
PHQ-2 screenings in visit documentation and other than procedure visits, this wasn’t correlated
with any specific visit reason. It was found that patients did not have a higher mean PHQ-2
score during the COVID-19 pandemic when compared to before. The patients actually had a
slightly lower PHQ-2 score in December 2020-February 2021. Additionally, no age group,
gender, or race/ethnicity emerged as having a greater change in PHQ-2 score between the two
time frames. It was difficult to examine the change in utilization of behavioral health services
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as the availability of behavioral health providers reduced drastically. However, behavioral
health visits completed via telemedicine increased dramatically in April 2020 and maintained
around 50% for the remainder of the year.
The results of the project were unexpected and inconsistent with earlier national
findings of an increase in depression symptoms in American adults (Ettman, et al., 2020).
Although the results were unexpected, there are a few possible explanations for the decrease in
depression symptoms during the COVID-19 pandemic. Typically, patents at an FQHC are of a
low-socioeconomic status. The temporary income supports passed by Congress in late
December 2020 are estimated to have reduced poverty from 16.1% in December of 2020 to
13.2% in January 2021 (Parolin & Curran, 2021). Those with the lowest income are 1.5 to 3
times more likely to experience depression and anxiety (Ridley, et al., 2020). Ridley et al.
established a bidirectional causal relationship between poverty and mental illness. Poverty is
associated with volatile earnings and expenses resulting in increased worrying which can
worsen mental health. One possibility is that the stimulus, increased unemployment benefits,
and increased SNAP benefits protected against mental health symptoms commonly associated
with decreased income.
Additionally, the FQHC joined with other healthcare organizations in the region to
create a coalition intended to meet needs that emerged while affected by COVID-19 in
Hispanic and Marshallese populations. The services provided included food, help with rent and
utilities, and assistance with navigation of healthcare needs and employment issues that arose
due to COVID-19. Suggested future research includes identifying if the patients that benefited
from this resource had less stress, anxiety, or depression during the COVID-19 pandemic.
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Another possible explanation for the unexpected results could be related to the clinic’s
historical success with an integrated behavioral health model. The patients that received
primary care at the clinic prior to the COVID-19 pandemic were likely screened with the
PHQ-2 and offered behavioral health services as indicated. This previous behavioral health
support may have set the patients up for success when coping with obstacles encountered
during the pandemic.
One major difficulty identified in the study was the shortage of mental health providers.
The FQHC currently has four open positions for LCSWs. These positions have been open for
months. One recommendation for the FQHC would be to consider referring insured patients to
remote behavioral health services while focusing the in-house services on uninsured patients.
Specifically, remote behavioral health providers at another FQHC. This would allow more
patients to receive services while the clinic lacks behavioral health providers.
Economic and Cost Benefits
Depression is one of the most financially burdensome disorders in the United States
(Greenberg et al., 2015).  The economic burden of individuals with major depressive disorder
in 2010 was $210.5 billion.  This includes direct medical costs, suicide-related mortality costs,
and indirect workplace costs.  Furthermore, improved screening, identification, and treatment
could reduce the financial burden of the disease (Jiao et al., 2017).
The cost of this project includes the time the staff spends administering the depression
screening tool.  Using the PHQ-2 preliminarily and then proceeding to the PHQ-9 as indicated
is a cost-effective strategy (Jiao et al., 2017). If patients screen positive for depression
symptoms and a behavioral health referral is indicated, the additional visits with behavioral
health are an economic benefit to the clinic.  Additionally, in response to COVID-19 the 1135
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waiver was enacted by the Centers for Medicare and Medicaid Services (CMS) which allows
for increased reimbursement for telemedicine services (CMS, 2020).  This allowed the FQHC
to be reimbursed for telehealth behavioral health services when previously this reimbursement
was not available. Many patients presenting for COVID-19 testing or vaccination are new to
the clinic.  Screening them for depression and referring to behavioral health as indicated will
promote the continued use of services at the clinic by these new patients.  The screening
process will also increase awareness of behavioral health services offered at the clinic.
Limitations
Limitations of this project include that it examined data from only one health system
with all locations in the Northwest Arkansas area. Transferability may be limited as the data
only includes patients from an FQHC which may not be comparable to the general population.
Another limitation is the data only includes a three-month time frame. Opening up the time
frame to include the beginning of the COVID-19 pandemic may be more informative.
Imprecision in the design related to the screening rate is another limitation. Initially it
was planned to notify care teams when their PHQ-2 screening rate fell below a specific
threshold, but, when examining the data, practical implications limited the specificity of this
metric.  For example, some care teams may have seen very few adult patients in the previous
week, and, therefore, their screening rate was not significant and did not warrant notification.
Sustainability
The FQHC aims to continue universal screening of adults with the PHQ-2 screening
tool. The Quality Department plans to increase visibility of each care team’s adherence to all




The FQHC continuously aims to increase their preventative health screening rates. This
includes screenings for depression, cancer, diabetes, hypertension, and others. This project
utilized a simple strategy of making care teams aware of their current screening rate when their
rates fell below the clinic’s goal. This strategy may be useful in increasing preventative
screening rates other than depression. Additionally, completing chart reviews to determine if
positive screenings were addressed in visit documentation helps to keep the care teams mindful
of areas for improvement. The data analyzed on depression symptoms informs the FQHC of
current risk factors in their patient population. The report and analysis could be completed at
different time frames in the future in order to examine how the rates of depression symptoms
shift over time and if any population groups should be targeted for intervention.
There has been a robust response to the COVID-19 pandemic locally and nationally.
Most recently, the American Rescue Plan Act became law on March 11, 2021 (Congress,
2021). This includes another round of stimulus checks, funding aimed at reopening schools, and
funding for vaccinations. It is estimated that this plan will reduce the annual poverty rate from
13.7% to 8.7% and lessen child poverty by half (Wheaton, et al., 2021).
The increase of remote mental health services during the COVID-19 pandemic may
improve the access to mental healthcare moving forward. According to a survey from the US
Census Bureau, the number of participants that reported having received mental health services
in the past 4 weeks increased from 19.4% to 21.1% from August 2020 to February 2021 (CDC,
2021). The percentage of Arkansans that reported having received counseling or therapy in the
past 4 weeks increased from 6.1% in August 2020 to 12.4% in February 2021. Future policies
that may increase access to care include examining state insurance and provider licensing laws
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in order to encourage mental health parity and continuing to strengthen telehealth infrastructure
(Warren & Smalley, 2021). The Temporary Reciprocity to Ensure Access to Treatment
(TREAT) Act was introduced on February 2, 2021 which will provide licensing reciprocity for
healthcare professionals for any type of service provided to a patient located in another state
(AAMC, 2021).
The FQHC will continue to promote universal depression screening of adult patients
with a goal screening rate of 80%. The FQHC aims to increase preventative health practices
overall with changes in the EMR and templates that promote a focus on preventative care.
Translation
The interventions within this study can be translated to other outpatient primary care
clinics that offer behavioral health services.  This project may be specifically relevant to other
FQHCs.
Dissemination
The results of this project will be presented at the University of Arkansas Eleanor Mann
School of Nursing DNP intensive on April 13, 2021. A poster presentation will be completed in
order to visually convey the results.
The project will also be disseminated at the clinical site. A PowerPoint presentation will
be created and presented to the Quality Department via Zoom. PowerPoint was selected for this
presentation as it is an appropriate and engaging presentation tool for use on a remote digital
platform such as Zoom. The Quality Department is essential in developing and implementing




The poster presentation will also be presented at the 2021 Arkansas Nurse Practitioner
Conference in October.  It is important in dissemination of this project to recognize the role
primary care providers serve in addressing behavioral healthcare needs. Considering this, one
peer-reviewed journal that would be appropriate for submission of this project is The Nurse
Practitioner: The American Journal of Primary Healthcare.
Conclusion
Despite the unexpected results of this project, it remains vital to integrate behavioral
health care with primary care (HRSA, 2020). This integration can involve the use of validated
screening tools and appropriate referral upon positive screening. During the COVID-19
pandemic, patients may face unprecedented challenges that increase their need for behavioral
health services. It is important to improve the accessibility of these services through avenues
such as telemedicine.
Further research recommendations include examining the data on depression symptoms
throughout the entire pandemic compared to previous years in order to determine how depression
symptoms may have changed throughout the pandemic. Additionally, comparing the results of
this project to a similar project in a traditional clinic setting as opposed to an FQHC. Another
possibility for future research would be to use HRSA data to compare depression symptoms in
patients at FQHCs throughout the pandemic nationally.
Upon the development of this project, the future of the pandemic and negative mental
health symptoms seemed bleak. Throughout the fall, COVID-19 cases and deaths rose with no
apparent end in sight. At the start of implementation in December, vaccinations were just on the
horizon. As of March 22, 13.45% of the US population has received at least one dose of the
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COVID-19 vaccine with numbers growing by millions each day (WHO, 2021). With the future
of the pandemic still unknown but optimistic, it is important to continue to provide
comprehensive care considering psychological and sociological impacts on health.
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E. Gantt Chart Timeline, Expected vs. Actual
61
F. Statement of Mutual Agreement for DNP Guidance
62
G. Needs Assessment Questionnaire
Mental Health Care Amid COVID-19
The purpose of this questionnaire is to gain insight from Community Clinic staff regarding gaps
in mental health care related to the COVID-19 pandemic. This information will contribute to a
better understanding of gaps in care, strategies that have been used to reduce gaps, and
identification of new strategies.
Please list your role:
Years of Experience:
1. Have you identified a gap in mental health care related to COVID-19?
2. Why do you think this gap in care exists?
3. Have you identified any poor health outcomes due to this gap in care?
4. What strategies have been implemented to address this gap in care?
5. What strategies would you recommend to address this gap in care?
6. Do you feel the staff would support an initiative to improve this gap in care?
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